Standard

Seroprevalence of fourteen human polyomaviruses determined in blood donors. / Kamminga, Sergio; van der Meijden, Els; Feltkamp, Mariet C. W. et al.

In: PLoS ONE, Vol. 13, No. 10, e0206273, 2018.

Research output: Contribution to journal › Article › Academic › peer-review

Harvard

Kamminga, S, van der Meijden, E, Feltkamp, MCW & Zaaijer, HL 2018, 'Seroprevalence of fourteen human polyomaviruses determined in blood donors', PLoS ONE, vol. 13, no. 10, e0206273. https://doi.org/10.1371/journal.pone.0206273

APA

Kamminga, S., van der Meijden, E., Feltkamp, M. C. W., & Zaaijer, H. L. (2018). Seroprevalence of fourteen human polyomaviruses determined in blood donors. PLoS ONE, 13(10), [e0206273]. https://doi.org/10.1371/journal.pone.0206273

Vancouver

Kamminga S, van der Meijden E, Feltkamp MCW, Zaaijer HL. Seroprevalence of fourteen human polyomaviruses determined in blood donors. PLoS ONE. 2018;13(10):e0206273. doi: 10.1371/journal.pone.0206273

Author

Kamminga, Sergio ; van der Meijden, Els ; Feltkamp, Mariet C. W. et al. / Seroprevalence of fourteen human polyomaviruses determined in blood donors. In: PLoS ONE. 2018 ; Vol. 13, No. 10.

BibTeX

@article{c817ee7b90ed4c3c9d7b884018ce7f2c,
title = "Seroprevalence of fourteen human polyomaviruses determined in blood donors",
abstract = "The polyomavirus family currently includes thirteen human polyomavirus (HPyV) species. In immunocompromised and elderly persons HPyVs are known to cause disease, such as progressive multifocal leukoencephalopathy (JCPyV), haemorrhagic cystitis and nephropathy (BKPyV), Merkel cell carcinoma (MCPyV), and trichodysplasia spinulosa (TSPyV). Some recently discovered polyomaviruses are of still unknown prevalence and pathogenic potential. Because HPyVs infections persist and might be transferred by blood components to immunocompromised patients, we studied the seroprevalence of fourteen polyomaviruses in adult Dutch blood donors. For most polyomaviruses the observed seroprevalence was high (60-100%), sometimes slightly increasing or decreasing with age. Seroreactivity increased with age for JCPyV, HPyV6 and HPyV7 and decreased for BKPyV and TSPyV. The most recently identified polyomaviruses HPyV12, NJPyV and LIPyV showed low overall seroprevalence (~5%) and low seroreactivity, questioning their human tropism. Altogether, HPyV infections are common in Dutch blood donors, with an average of nine polyomaviruses per subject.",
author = "Sergio Kamminga and {van der Meijden}, Els and Feltkamp, {Mariet C. W.} and Zaaijer, {Hans L.}",
year = "2018",
doi = "10.1371/journal.pone.0206273",
language = "English",
volume = "13",
journal = "PLoS ONE",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "10",

}

RIS

TY - JOUR

T1 - Seroprevalence of fourteen human polyomaviruses determined in blood donors

AU - Kamminga, Sergio

AU - van der Meijden, Els

AU - Feltkamp, Mariet C. W.

AU - Zaaijer, Hans L.

PY - 2018

Y1 - 2018

N2 - The polyomavirus family currently includes thirteen human polyomavirus (HPyV) species. In immunocompromised and elderly persons HPyVs are known to cause disease, such as progressive multifocal leukoencephalopathy (JCPyV), haemorrhagic cystitis and nephropathy (BKPyV), Merkel cell carcinoma (MCPyV), and trichodysplasia spinulosa (TSPyV). Some recently discovered polyomaviruses are of still unknown prevalence and pathogenic potential. Because HPyVs infections persist and might be transferred by blood components to immunocompromised patients, we studied the seroprevalence of fourteen polyomaviruses in adult Dutch blood donors. For most polyomaviruses the observed seroprevalence was high (60-100%), sometimes slightly increasing or decreasing with age. Seroreactivity increased with age for JCPyV, HPyV6 and HPyV7 and decreased for BKPyV and TSPyV. The most recently identified polyomaviruses HPyV12, NJPyV and LIPyV showed low overall seroprevalence (~5%) and low seroreactivity, questioning their human tropism. Altogether, HPyV infections are common in Dutch blood donors, with an average of nine polyomaviruses per subject.

AB - The polyomavirus family currently includes thirteen human polyomavirus (HPyV) species. In immunocompromised and elderly persons HPyVs are known to cause disease, such as progressive multifocal leukoencephalopathy (JCPyV), haemorrhagic cystitis and nephropathy (BKPyV), Merkel cell carcinoma (MCPyV), and trichodysplasia spinulosa (TSPyV). Some recently discovered polyomaviruses are of still unknown prevalence and pathogenic potential. Because HPyVs infections persist and might be transferred by blood components to immunocompromised patients, we studied the seroprevalence of fourteen polyomaviruses in adult Dutch blood donors. For most polyomaviruses the observed seroprevalence was high (60-100%), sometimes slightly increasing or decreasing with age. Seroreactivity increased with age for JCPyV, HPyV6 and HPyV7 and decreased for BKPyV and TSPyV. The most recently identified polyomaviruses HPyV12, NJPyV and LIPyV showed low overall seroprevalence (~5%) and low seroreactivity, questioning their human tropism. Altogether, HPyV infections are common in Dutch blood donors, with an average of nine polyomaviruses per subject.

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85055607332&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/30352098

U2 - 10.1371/journal.pone.0206273

DO - 10.1371/journal.pone.0206273

M3 - Article

C2 - 30352098

VL - 13

JO - PLoS ONE

JF - PLoS ONE

SN - 1932-6203

IS - 10

M1 - e0206273

ER -

ID: 5676636